Pharmaceutical Patents in Malta
The lack of pharmaceutical patents issued, provides fundamental opportunities for generic pharmaceutical companies to develop and produce in Malta.
The reasons why the generic pharmaceutical industry has become one of Malta's most influential industries are based on the patent legislation, initiatives to expand the generic pharmaceutical sector and Malta's geographical location.
These offer a unique and very attractive marketing perspective for generic pharmaceutical manufacturers.
Related Topic: » SPC: Supplementary Protection Certificates / Supplementary Protection Certificates in Malta
The reasons why the generic pharmaceutical industry has become one of Malta's most influential industries are based on the patent legislation, initiatives to expand the generic pharmaceutical sector and Malta's geographical location.
These offer a unique and very attractive marketing perspective for generic pharmaceutical manufacturers.
Why patenting pharmaceuticals in Malta?
- Lack of pharmaceutical patents issued;
- Bolar exemption in the Maltese Patent Legislation;
- Malta's geographical location and its marketing perspectives for generic pharmaceutical manufacturers:
- Easy access to existing trade routes;
- Malta as an EU Member State;
- Easy access to North African markets;
- Pharmaceutical initiatives by Malta Enterprise (Malta Enterprise: Government Agency which coordinates commercial development,
trade and foreign investment);
Related Topic: » SPC: Supplementary Protection Certificates / Supplementary Protection Certificates in Malta